J&J keeps cash flowing on blockbuster Pharmacyclics deal for ibrutinibFierceBiotech… up with its third $50 million payday for the Btk inhibitor as the fifth patient with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lympho…
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III …Equities.comSUNNYVALE, Calif., Oct. 15, 2012 /PRNewswire/ — Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international, randomized Phase III clinical trial …
Pharmacyclics gets $50M milestone payment from J&JMarketWatchThe trial involves Pharmacyclics's drug ibrutinib in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocy…
Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III …Sacramento BeeSUNNYVALE, Calif., Oct. 15, 2012 — /PRNewswire/ — Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international, randomized Phase III clinical t…
Weiger surviving the worst surrounded by family, friends, faithSuburban Life PublicationsDoctors now are trying an intravenous medication called Rituximab given to Johnny once a week for four weeks. He received his second dose this week. The medication…
Antikörpertherapie: Frauen reagieren besserDocCheck NewsDie Studie hat ergeben, dass der Blutspiegel (Serumspiegel) bei den Frauen über den Zeitraum der Therapie mit Rituximab um 20 Prozent höher ist als bei Männern. Frauen erreichen die Sättigung…
Anti-cancer drug fights immune reaction in some infants with Pompe diseaseMedical XpressImmune modulation with rituximab (anti-CD20 monoclonal antibody), plus methotrexate and intravenous gamma globulin (IVIG) in infantile CRIM-negative Pompe patients …
Women respond much better than men to treatment of CFL with rituximabNews-Medical.netWomen respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of …
Lymphdrüsenkrebs: Frauen reagieren besser auf AntikörperderStandard.atDie Studie hat ergeben, dass der Blutspiegel (Serumspiegel) bei Frauen über den Zeitraum der Therapie mit Rituximab um 20 Prozent höher ist als bei Männern. Außerdem erreichen …
Seattle Genetics Will Get Undisclosed Milestone PaymentsEquities.comThe phase II randomized, open-label study is designed to evaluate the safety and efficacy of ADCs anti-CD22 (DCDT2980S, RG7593) and DCDS4501A (RG7596) each in combination with Rituxan